Markets
markets

Pfizer beats earnings estimates thanks to cost cuts

Pfizer beat Wall Street earnings estimates for the first three months of this year, fueled largely by an aggressive cost-cutting campaign.

Pfizer reported adjusted earnings per share of $0.92, higher than the $0.67 analysts polled by FactSet were expecting. The drugmaker also reported $13.7 billion in revenue, less than the $13.9 billion analysts were penciling in.

The company has cut an additional $1.2 billion in costs, with the goal of cutting $4.5 billion by the end of the year. Pfizer is trying to get leaner while it searches for its next blockbuster drug.

Management also reaffirmed its 2025 outlook, which “does not currently include any potential impact related to future tariffs and trade policy changes, which we are unable to predict at this time.”

Shares are modestly higher in premarket trading as prepared remarks from CFO David Denton suggest that the company is “currently trending toward the upper end” of its profit guidance, excluding any trade-related impacts.

More Markets

See all Markets
markets

SpaceX gets a wave of bullish ratings from Wall Street analysts

SpaceX received more than a dozen positive analyst calls on Tuesday — including from major Wall Street banks — as they initiate coverage on Elon Musk’s space and AI company.

SpaceX went public on June 12 at a $2.2 trillion valuation, the largest debut in history. While the company hasn’t yet posted a profit, it seems to have convinced Wall Street that it will get there and grow its valuation on the way.

Of the at least 17 analysts that gave a rating on Tuesday, all but one gave it a “buy” or “outperform” rating. MoffettNathanson was "neutral."

The ratings come as SpaceX joined the Nasdaq 100 index, a benchmark tech-heavy basket of companies that underpins millions of portfolios. The inclusion adds built-in demand for the stock from index funds and ETFs.

Still, SpaceX fell more than 5% on Tuesday amid a broader sell-off, and is currently effectively flat from its opening price of $150 a share.

Latest Stories

Sherwood Media, LLC and Chartr Limited produce fresh and unique perspectives on topical financial news and are fully owned subsidiaries of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Money, LLC, Robinhood U.K. Ltd, Robinhood Derivatives, LLC, Robinhood Gold, LLC, Robinhood Asset Management, LLC, Robinhood Credit, Inc., Robinhood Ventures DE, LLC and, where applicable, its managed investment vehicles.